This compound, a complex of bis(3-bromophenylboronic acid) with scyllo-inositol and dipotassium pentahydrate, is primarily utilized in medicinal chemistry and biochemistry. It targets enzymes involved in inositol-related metabolic pathways, aiding research into treatments for disorders such as diabetes and neurological conditions. The scyllo-inositol component is key for studying cellular signaling and biological processes involving inositols. Additionally, it supports the synthesis of complex molecules for drug discovery and potential therapeutic agents. Its boronic acid moieties enable Suzuki-Miyaura cross-coupling reactions, facilitating carbon-carbon bond formation in organic synthesis for pharmaceuticals and biologically active compounds.